Related references
Note: Only part of the references are listed.Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone
Stephanie A. Harmon et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Repeatability of SUV in Oncologic 18F-FDG PET
Martin A. Lodge
JOURNAL OF NUCLEAR MEDICINE (2017)
Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study
Raquel Perez-Lopez et al.
RADIOLOGY (2017)
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Hope S. Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
Christie Lin et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease
Matthew D. Blackledge et al.
PLOS ONE (2016)
Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases - A correlation study with histology
Maximilian Merz et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by F-18-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687
Evan Y. Yu et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
18F-Fluoride PET Used for Treatment Monitoring of Systemic Cancer Therapy: Results from the National Oncologic PET Registry
Bruce E. Hillner et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group
F. E. Lecouvet et al.
EUROPEAN JOURNAL OF CANCER (2014)
18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes
Hye Ryoung Koo et al.
EUROPEAN RADIOLOGY (2014)
Therapy monitoring of skeletal metastases with whole-body diffusion MRI
Anwar R. Padhani et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countries
H. Hoefeler et al.
JOURNAL OF BONE ONCOLOGY (2014)
Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers
Takashi Katayama et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Factors associated with mortality after breast cancer metastasis
Su Yon Jung et al.
CANCER CAUSES & CONTROL (2012)
Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study
Nina Mortazavi-Jehanno et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Assessing response in bone metastases in prostate cancer with diffusion weighted MRI
C. Messiou et al.
EUROPEAN RADIOLOGY (2011)
Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility
C. Messiou et al.
EUROPEAN RADIOLOGY (2011)
Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis
Tobias Baeuerle et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Kinetic Analysis of 18F-Fluoride PET Images of Breast Cancer Bone Metastases
Robert K. Doot et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Bone Metastases from Prostate Cancer: Assessing Treatment Response by Using Diffusion-weighted Imaging and Functional Diffusion Maps-Initial Observations
Carolin Reischauer et al.
RADIOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Bone metastases in patients with metastatic breast cancer: Morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT
Ukihide Tateishi et al.
RADIOLOGY (2008)
Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)
Jennifer M. Specht et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
The measurement of pain from metastatic bone disease: Capturing the patient's experience
Charles S. Cleeland
CLINICAL CANCER RESEARCH (2006)
Flare response in F-18-fluoride ion PET bone scanning
AA Wade et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography
ML Frost et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women:: Analysis of survival and update of efficacy from the international letrozole breast cancer group
H Mouridsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy
SE Stafford et al.
ACADEMIC RADIOLOGY (2002)
Quantitative studies of bone with the use of F-18-fluoride and Tc-99m-methylene diphosphonate
GM Blake et al.
SEMINARS IN NUCLEAR MEDICINE (2001)
Risk of complications from bone metastases in breast cancer: implications for management
TA Plunkett et al.
EUROPEAN JOURNAL OF CANCER (2000)